Literature DB >> 14614132

Regulation of survivin function by Hsp90.

Paola Fortugno1, Elena Beltrami, Janet Plescia, Jason Fontana, Deepti Pradhan, Pier Carlo Marchisio, William C Sessa, Dario C Altieri.   

Abstract

Pathways controlling cell proliferation and cell survival require flexible adaptation to environmental stresses. These mechanisms are frequently exploited in cancer, allowing tumor cells to thrive in unfavorable milieus. Here, we show that Hsp90, a molecular chaperone that is central to the cellular stress response, associates with survivin, an apoptosis inhibitor and essential regulator of mitosis. This interaction involves the ATPase domain of Hsp90 and the survivin baculovirus inhibitor of apoptosis repeat. Global suppression of the Hsp90 chaperone function or targeted Abmediated disruption of the survivin-Hsp90 complex results in proteasomal degradation of survivin, mitochondrial-dependent apoptosis, and cell cycle arrest with mitotic defects. These data link the cellular stress response to an antiapoptotic and mitotic checkpoint maintained by survivin. Targeting the survivin-Hsp90 complex may provide a rational approach for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614132      PMCID: PMC283500          DOI: 10.1073/pnas.2434345100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Protein unfolding by mitochondria. The Hsp70 import motor.

Authors:  A Matouschek; N Pfanner; W Voos
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

2.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

Authors:  M S Soengas; P Capodieci; D Polsky; J Mora; M Esteller; X Opitz-Araya; R McCombie; J G Herman; W L Gerald; Y A Lazebnik; C Cordón-Cardó; S W Lowe
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

3.  Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.

Authors:  M A Verdecia; H Huang; E Dutil; D A Kaiser; T Hunter; J P Noel
Journal:  Nat Struct Biol       Date:  2000-07

Review 4.  From the cradle to the grave: molecular chaperones that may choose between folding and degradation.

Authors:  J Höhfeld; D M Cyr; C Patterson
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

Review 5.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

6.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.

Authors:  M Srethapakdi; F Liu; R Tavorath; N Rosen
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

8.  The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains.

Authors:  C Prodromou; B Panaretou; S Chohan; G Siligardi; R O'Brien; J E Ladbury; S M Roe; P W Piper; L H Pearl
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

9.  Inhibition of melanoma tumor growth in vivo by survivin targeting.

Authors:  D Grossman; P J Kim; J S Schechner; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

Review 10.  Hsp90: a specialized but essential protein-folding tool.

Authors:  J C Young; I Moarefi; F U Hartl
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  94 in total

1.  Combined in silico and experimental approach for drug design: the binding mode of peptidic and non-peptidic inhibitors to hsp90 N-terminal domain.

Authors:  Simona Tomaselli; Massimiliano Meli; Janet Plescia; Lucia Zetta; Dario C Altieri; Giorgio Colombo; Laura Ragona
Journal:  Chem Biol Drug Des       Date:  2010-11       Impact factor: 2.817

2.  Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.

Authors:  Pablo E Vivas-Mejia; Cristian Rodriguez-Aguayo; Hee-Dong Han; Mian M K Shahzad; Fatma Valiyeva; Mineko Shibayama; Arturo Chavez-Reyes; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2011-04-21       Impact factor: 12.531

3.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

Review 4.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

5.  Activation of dual apoptotic pathways in human melanocytes and protection by survivin.

Authors:  Tong Liu; Diana Biddle; Adrianne N Hanks; Brook Brouha; Hui Yan; Ray M Lee; Sancy A Leachman; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

6.  Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

Authors:  Takehiko Dohi; Elena Beltrami; Nathan R Wall; Janet Plescia; Dario C Altieri
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

8.  The effects of Hsp90 expression alteration on spinal metastases of breast carcinoma.

Authors:  Wangjun Yan; Jianru Xiao; Tielong Liu; Wending Huang; Xinghai Yang; Zhipeng Wu; Quan Huang; Ming Qian
Journal:  Tumour Biol       Date:  2013-03-01

9.  Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.

Authors:  Canan Akfirat; Xiaotun Zhang; Aviva Ventura; Dror Berel; Mary E Colangelo; Cindy K Miranti; Maryla Krajewska; John C Reed; Celestia S Higano; Lawrence D True; Robert L Vessella; Colm Morrissey; Beatrice S Knudsen
Journal:  J Pathol       Date:  2013-07       Impact factor: 7.996

10.  Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo.

Authors:  Andrew W Hoel; Peng Yu; Khanh P Nguyen; Xinxin Sui; Janet Plescia; Dario C Altieri; Michael S Conte
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.